Lee C Y, Rechler M M
Growth and Development Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Endocrinology. 1995 Feb;136(2):668-78. doi: 10.1210/endo.136.2.7530649.
Insulin-like growth factor-II (IGF-II) binds to 150-kilodalton (kDa) protein complexes in adult rat serum that have higher affinity for IGF-II than IGF-I. We now examine the nature of these IGF-II-preferring complexes. A 150-kDa pool, isolated after neutral Sephadex G-200 gel filtration of adult rat serum, bound IGF-II with approximately 80-fold greater affinity than IGF-I, but did not contain immunoprecipitable IGF-II/mannose-6-phosphate receptors, which bind IGF-II with the same preferential affinity. Exogenous IGF-II bound to the 150-kDa complex without displacing endogenous IGF-I, indicating that it bound to sites that were previously unoccupied. IGF-I affinity chromatography was used to separate unoccupied 150-kDa complexes that bound to the column and were eluted with acid from complexes that contained endogenous IGF-I, did not bind to the column, and appeared in the flow-through. In competitive binding assays, IGF-binding proteins (IGFBPs) in the acid eluate bound IGF-II with higher affinity than IGF-I, whereas IGFBPs in the flow-through, after acid stripping, bound IGF-I and IGF-II with similar affinity. The acid eluate and the acid-stripped flow-through predominantly formed 50-kDa complexes with [125I]IGF-II when affinity-cross-linked and examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis; these complexes were precipitated by antibodies to rat IGFBP-3. Larger complexes (> 95 kDa) present in the nonacidified 150-kDa pool were not observed, consistent with the IGFBP-3 molecules in the flow-through and eluate having been complexed to an acid-labile subunit (ALS). By contrast, when these preparations were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis without affinity cross-linking, the flow-through contained intact IGFBP-3 (40-43 kDa), whereas the eluate contained only truncated 30-kDa IGFBP-3. We conclude that the 150-kDa fraction of adult rat serum includes 1) ternary complexes of intact IGFBP-3 (which binds IGF-I and IGF-II with similar affinity), endogenous IGF-I, and the ALS; and 2) binary complexes of proteolytically nicked IGFBP-3 and ALS that bind IGF-II preferentially. The nicked IGF-II-preferring complex is present in native serum before acidification or exposure to denaturants.
胰岛素样生长因子-II(IGF-II)与成年大鼠血清中的150千道尔顿(kDa)蛋白复合物结合,这些复合物对IGF-II的亲和力高于IGF-I。我们现在研究这些优先结合IGF-II的复合物的性质。通过中性葡聚糖凝胶G-200对成年大鼠血清进行凝胶过滤后分离出的150-kDa组分,其结合IGF-II的亲和力比IGF-I高约80倍,但不包含可免疫沉淀的IGF-II/甘露糖-6-磷酸受体,该受体以相同的优先亲和力结合IGF-II。外源性IGF-II与150-kDa复合物结合而不置换内源性IGF-I,表明它结合到了先前未被占据的位点。利用IGF-I亲和色谱法将结合到柱上并用酸洗脱的未被占据的150-kDa复合物与含有内源性IGF-I、不结合到柱上并出现在流穿液中的复合物分开。在竞争性结合试验中,酸洗脱液中的IGF结合蛋白(IGFBPs)结合IGF-II的亲和力高于IGF-I,而酸剥离后的流穿液中的IGFBPs结合IGF-I和IGF-II的亲和力相似。当进行亲和交联并用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析时,酸洗脱液和酸剥离后的流穿液主要与[125I]IGF-II形成50-kDa复合物;这些复合物可被抗大鼠IGFBP-3抗体沉淀。在未酸化的150-kDa组分中未观察到更大的复合物(>95 kDa),这与流穿液和洗脱液中的IGFBP-分子已与酸不稳定亚基(ALS)复合一致。相比之下,当通过不进行亲和交联的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析这些制剂时,流穿液中含有完整的IGFBP-3(40 - 43 kDa),而洗脱液中仅含有截短的30-kDa IGFBP-3。我们得出结论,成年大鼠血清的150-kDa组分包括:1)完整IGFBP-3(以相似亲和力结合IGF-I和IGF-II)、内源性IGF-I和ALS的三元复合物;以及2)优先结合IGF-II的蛋白水解切割的IGFBP-3和ALS的二元复合物。这种切割后优先结合IGF-II的复合物在酸化或暴露于变性剂之前存在于天然血清中。